发明名称 ANTIBODY TO OX-2/CD200 AND USE THEREOF
摘要 <p>PROBLEM TO BE SOLVED: To provide agents and methods for modulating the function of CD200.SOLUTION: Disclosed are agents for modulating the function of CD200, and the agents include modulating agents for the activity and/or expression of CD200 and/or its receptor (CD200R). In some embodiments, the agents inhibit the function or activity of CD200. Thus in certain aspects, the agents act as antagonists to CD200. Certain antagonists may bind to CD200 and inhibit or disrupt the interaction of CD200 with its receptor. Other antagonists may bind to CD200 but may not block the CD200:CD200R interaction. Thus CD200 antagonists include any agent that is capable of modulating the effects of CD200 by mechanisms that may or may not include blocking the CD200:CD200R interaction.</p>
申请公布号 JP2014156487(A) 申请公布日期 2014.08.28
申请号 JP20140112056 申请日期 2014.05.30
申请人 ALEXION PHARMACEUTICALS INC 发明人 BOWDISH KATHERINE S;KRETZ-ROMMEL ANKE;FAAS MCKNIGHT SUSAN;SPRINGHORN JEREMY P;WU DAYANG
分类号 C07K16/28;A61K31/138;A61K31/167;A61K31/337;A61K31/454;A61K31/4745;A61K31/506;A61K31/513;A61K31/52;A61K31/56;A61K31/675;A61K31/704;A61K31/7056;A61K31/7068;A61K31/7072;A61K31/7076;A61K31/7088;A61K31/7105;A61K31/711;A61K31/713;A61K33/00;A61K33/24;A61K38/00;A61K38/21;A61K39/00;A61K39/395;A61K45/00;A61K49/00;A61K49/04;A61P11/00;A61P13/08;A61P13/12;A61P15/00;A61P17/00;A61P25/00;A61P31/12;A61P35/00;A61P35/02;A61P43/00;C12N15/02;C12N15/09 主分类号 C07K16/28
代理机构 代理人
主权项
地址